Jonay Barnes
Senior Vice President, Investor Relations and Corporate Communication, Atea Pharmaceuticals
Replay available
Atea Pharmaceuticals, Inc. (AVIR) Q3 2025 Earnings Call
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Andrea Corcoran
Chief Financial Officer and Executive Vice President of Legal, Atea Pharmaceuticals
Dr. Janet Hammond
Chief Development Officer, Atea Pharmaceuticals
Dr. Arantja Horga
Chief Medical Officer, Atea Pharmaceuticals
Dr. John-Pierre Sommadosi
Chief Executive Officer and Founder, Atea Pharmaceuticals
Andy Shea
Analyst, William Blair
John Vavrica
Chief Commercial Officer, Atea Pharmaceuticals
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Atea Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.257 Good afternoon, everyone, and welcome to the ATF Pharmaceuticals 3rd Quarter 00:00:05.257 -- 00:00:09.922 2025 Financial Results and Business Update Conference Call. 00:00:09.922 -- 00:00:13.846 At this time, all participants are in listen-only mode. 00:00:13.846 -- 00:00:18.929 Following the formal remarks, we'll open the call up for your questions. 00:00:19.111 -- 00:00:24.057 I would now like to turn the call over to Jonay Barnes, Senior Vice President of Investor 00:00:24.057 -- 00:00:28.361 Relations and Corporate Communication at ATF Pharmaceuticals. 00:00:28.361 -- 00:00:31.013 Ms. Barnes, please proceed. 00:00:31.013 -- 00:00:36.000 Thank you, Operator. Good afternoon, everyone, and welcome to Atea Pharmaceutical's third 00:00:36.000 -- 00:00:40.346 quarter 2025 financial results and business update conference call. 00:00:40.346 -- 00:00:45.292 Earlier today, we issued a press release which outlines the topics we plan to discuss. 00:00:45.292 -- 00:00:49.358 You can access the press release as well as the slides that we'll be reviewing today 00:00:49.358 -- 00:00:54.362 by going to the investor section of our website at ir.ateafarma.com. 00:00:54.885 -- 00:00:58.910 With me from Atea are our Chief Executive Officer and Founder, Dr. 00:00:58.910 -- 00:01:02.238 John-Pierre Sommadosi, Chief Development Officer, Dr. 00:01:02.238 -- 00:01:07.786 Janet Hammond, Chief Medical Officer, Dr. Arantja Horga, Chief Commercial Officer, 00:01:07.786 -- 00:01:13.053 John Vavrica, and Chief Financial Officer and Executive Vice President of Legal, 00:01:13.053 -- 00:01:18.300 Andrea Corcoran, all of whom will be available for the Q&A portion of today's call. 00:01:18.300 -- 00:01:23.026 Before we begin the call, and as outlined on slide two...